CZ ATC L01EA02 · updated 2 Nov 2026
Dasatinib shortage in Czechia
Is there a Dasatinib shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Dasatinib product is reported short in Czechia. The company estimate for the return is 31 Jan 2027. Main reason: increased demand.
Also short in Canada, Italy, Norway, Sweden, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | DASATINIB VIATRIS 50MG 50MG TBL FLM 60 anticipated | VIATRIS LIMITED, Dublin | 7 Nov 2026 | 31 Jan 2027 | Increased demand Zvýšené prodeje |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.